J. P. Ioannidis, Why most published research findings are false, PLoS Med, vol.2, p.124, 2005.

A. Compston and A. Coles, Multiple sclerosis, Lancet, vol.372, pp.1502-1519, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00996686

H. Lassmann, W. Bruck, and C. F. Lucchinetti, The immunopathology of multiple sclerosis: an overview, Brain Pathol, vol.17, pp.210-218, 2007.

R. A. Rudick, W. H. Stuart, and P. A. Calabresi, Natalizumab plus interferon beta-1a for relapsing multiple sclerosis, N Engl J Med, vol.354, pp.911-934, 2006.

S. L. Hauser, E. Waubant, and D. L. Arnold, B-cell depletion with rituximab in relapsing-remitting multiple sclerosis, N Engl J Med, vol.358, pp.676-88, 2008.

V. Devonshire, E. Havrdova, and E. W. Radue, Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study, Lancet Neurol, vol.11, pp.420-428, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00826734

U. C. Meier, G. Giovannoni, J. S. Tzartos, and G. Khan, Translational mini-review series on B cell subsets in disease. B cells in multiple sclerosis: drivers of disease pathogenesis and Trojan horse for Epstein-Barr virus entry to the central nervous system?, Clin Exp Immunol, vol.167, pp.1-6, 2012.

P. K. Stys, G. W. Zamponi, J. Van-minnen, and J. J. Geurts, Will the real multiple sclerosis please stand up?, Nat Rev Neurosci, vol.13, pp.507-521, 2012.

B. A. Hart, R. Q. Hintzen, and J. D. Laman, Multiple sclerosis -a response-to-damage model, Trends Mol Med, vol.15, pp.235-279, 2009.

B. Engelhardt, Molecular mechanisms involved in T cell migration across the blood-brain barrier, J Neural Transm, vol.113, pp.477-85, 2006.

X. Liu, S. Leung, and C. Wang, Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease, Nat Med, vol.16, pp.191-198, 2010.

B. A. Hart, B. Gran, and R. Weissert, EAE: imperfect but useful models of multiple sclerosis, Trends Mol Med, vol.17, pp.119-144, 2011.

H. Wekerle, A. Flugel, L. Fugger, G. Schett, and D. Serreze, Autoimmunity's next top models, Nat Med, vol.18, pp.66-70, 2012.

J. R. Oksenberg and S. E. Baranzini, Multiple sclerosis genetics-is the glass half full, or half empty?, Nat Rev Neurol, vol.6, pp.429-466, 2010.

S. Sawcer, G. Hellenthal, and M. Pirinen, Genetic risk and a primary role for cellmediated immune mechanisms in multiple sclerosis, Nature, vol.476, pp.214-223, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00996686

S. E. Baranzini and D. Nickles, Genetics of multiple sclerosis: swimming in an ocean of data, Curr Opin Neurol, vol.25, pp.239-284, 2012.

D. A. Hafler, A. Compston, and S. Sawcer, Risk alleles for multiple sclerosis identified by a genomewide study, N Engl J Med, vol.357, pp.851-62, 2007.

J. Palace, Multiple sclerosis associated with Leber's hereditary optic neuropathy, J Neurol Sci, vol.286, pp.24-31, 2009.

S. Stockler, M. Millner, B. Molzer, F. Ebner, E. Korner et al., Multiple sclerosis-like syndrome in a woman heterozygous for adrenoleukodystrophy, Eur Neurol, vol.33, pp.390-392, 1993.

J. H. Noseworthy, C. Lucchinetti, M. Rodriguez, and B. G. Weinshenker, Multiple sclerosis, N Engl J Med, vol.343, pp.938-52, 2000.

G. A. Rook, Hygiene hypothesis and autoimmune diseases, Clin Rev Allergy Immunol, vol.42, pp.5-15, 2012.

N. Kawakami, S. Lassmann, and Z. Li, The activation status of neuroantigenspecific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis, J Exp Med, vol.199, pp.185-97, 2004.

I. Bartholomaus, N. Kawakami, and F. Odoardi, Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions, Nature, vol.462, pp.94-102, 2009.

E. Bettelli, D. Baeten, A. Jager, R. A. Sobel, and V. K. Kuchroo, Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice, J Clin Invest, vol.116, pp.2393-402, 2006.

M. Munder, E. Bettelli, L. Monney, J. M. Slavik, L. B. Nicholson et al., Reduced self-reactivity of an autoreactive T cell after activation with cross-reactive non-self-ligand, J Exp Med, vol.196, pp.1151-62, 2002.

E. Ngono, A. Pettre, S. Salou, and M. , Frequency of circulating autoreactive T cells committed to myelin determinants in relapsing-remitting multiple sclerosis patients, Clin Immunol, vol.144, pp.117-143, 2012.

G. P. Owens, D. Gilden, M. P. Burgoon, X. Yu, and J. L. Bennett, Viruses and multiple sclerosis, Neuroscientist, vol.17, pp.659-76, 2011.

V. Padler-karavani, H. Yu, and H. Cao, Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for disease, Glycobiology, vol.18, pp.818-848, 2008.

T. Pham, C. J. Gregg, and F. Karp, Evidence for a novel human-specific xeno-autoantibody response against vascular endothelium, Blood, vol.114, pp.5225-5260, 2009.

S. L. Diaz, V. Padler-karavani, and D. Ghaderi, Sensitive and specific detection of the non-human sialic Acid N-glycolylneuraminic acid in human tissues and biotherapeutic products, PLoS One, vol.4, p.4241, 2009.

L. Shaw and R. Schauer, The biosynthesis of N-glycoloylneuraminic acid occurs by hydroxylation of the CMP-glycoside of N-acetylneuraminic acid, Biol Chem Hoppe Seyler, vol.369, pp.477-86, 1988.

P. Tangvoranuntakul, P. Gagneux, and S. Diaz, Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid, Proc Natl Acad Sci, vol.100, pp.12045-50, 2003.

G. R. Burgio and V. Monafo, Infectious mononucleosis fifty years after the discovery of the Paul-Bunnell test, Infection, vol.11, pp.1-5, 1983.

M. P. Pender, The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis, Neuroscientist, vol.17, pp.351-67, 2011.

M. F. Callan, L. Tan, and N. Annels, Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo, J Exp Med, vol.187, pp.1395-402, 1998.

D. Hochberg, T. Souza, C. M. Sullivan, J. L. Luzuriaga, K. Thorley-lawson et al., Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells, J Virol, vol.78, pp.5194-204, 2004.

D. B. Wilson, D. H. Wilson, and K. Schroder, Specificity and degeneracy of T cells, Mol Immunol, vol.40, pp.1047-55, 2004.

H. L. Lang, H. Jacobsen, and S. Ikemizu, A functional and structural basis for TCR cross-reactivity in multiple sclerosis, Nat Immunol, vol.3, pp.940-943, 2002.

C. Benoist and D. Mathis, Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry?, Nat Immunol, vol.2, pp.797-801, 2001.

H. Wekerle and R. Hohlfeld, Molecular mimicry in multiple sclerosis, N Engl J Med, vol.349, pp.185-191, 2003.

A. C. Van-sechel, J. J. Bajramovic, M. J. Van-stipdonk, C. Persoon-deen, S. B. Geutskens et al., EBV-induced expression and HLA-DR-restricted presentation by human B cells of alpha B-crystallin, a candidate autoantigen in multiple sclerosis, J Immunol, vol.162, pp.129-164, 1999.

R. M. Lucas, A. M. Hughes, and M. L. Lay, Epstein-Barr virus and multiple sclerosis, J Neurol Neurosurg Psychiatry, vol.82, pp.1142-1150, 2011.

A. Compston, Risk factors for multiple sclerosis: race or place?, J Neurol Neurosurg Psychiatry, vol.53, pp.821-824, 1990.

C. Confavreux, M. Hutchinson, M. M. Hours, P. Cortinovis-tourniaire, and T. Moreau, Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group, N Engl J Med, vol.339, pp.285-91, 1998.

B. Bahbouhi, L. Berthelot, and S. Pettre, Peripheral blood CD4+ T lymphocytes from multiple sclerosis patients are characterized by higher PSGL-1 expression and transmigration capacity across a human blood-brain barrier-derived endothelial cell line, J Leukoc Biol, vol.86, pp.1049-63, 2009.

E. Marino and S. T. Grey, B cells as effectors and regulators of autoimmunity, Autoimmunity, vol.45, pp.377-87, 2012.

A. Karni, M. Abraham, and A. Monsonego, Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response, J Immunol, vol.177, pp.4196-202, 2006.

K. E. Balashov, D. R. Smith, S. J. Khoury, D. A. Hafler, and H. L. Weiner, Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand, Proc Natl Acad Sci, vol.94, pp.599-603, 1997.

B. Bahbouhi, S. Pettre, and L. Berthelot, T cell recognition of self-antigen presenting cells by protein transfer assay reveals a high frequency of antimyelin T cells in multiple sclerosis, Brain, vol.133, pp.1622-1658, 2010.

L. Berthelot, D. A. Laplaud, and S. Pettre, Blood CD8+ T cell responses against myelin determinants in multiple sclerosis and healthy individuals, Eur J Immunol, vol.38, pp.1889-99, 2008.

S. K. Kim, M. Cornberg, X. Z. Wang, H. D. Chen, L. K. Selin et al., Private specificities of CD8 T cell responses control patterns of heterologous immunity, J Exp Med, vol.201, pp.523-556, 2005.

S. C. Clute, L. B. Watkin, and M. Cornberg, Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virusassociated infectious mononucleosis, J Clin Invest, vol.115, pp.3602-3614, 2005.

E. Golaszewska, E. Kurowska, M. Duk, and K. J. Paul, Bunnell antigen and a possible mechanism of formation of heterophile antibodies in patients with infectious mononucleosis, Acta Biochim Pol, vol.50, pp.1205-1216, 2003.

T. Morito, K. Kano, and F. Milgrom, Hanganutziu-Deicher antibodies in infectious mononucleosis and other diseases, J Immunol, vol.129, pp.2524-2532, 1982.

L. Battistini, L. Piccio, and B. Rossi, CD8+ T cells from patients with acute multiple sclerosis display selective increase of adhesiveness in brain venules: a critical role for P-selectin glycoprotein ligand-1, Blood, vol.101, pp.4775-82, 2003.

L. G. Baldini and L. M. Cro, Structure and function of VLA integrins: differential expression in B-cell leukemia/lymphoma, Leuk Lymphoma, vol.12, pp.197-203, 1994.

R. Planas, I. Jelcic, S. Schippling, R. Martin, and M. Sospedra, Natalizumab treatment perturbs memory-and marginal zone-like B-cell homing in secondary lymphoid organs in multiple sclerosis, Eur J Immunol, vol.42, pp.790-798, 2012.

S. Cepok, D. Zhou, and R. Srivastava, Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis, J Clin Invest, vol.115, pp.1352-60, 2005.

S. Leech, J. Kirk, J. Plumb, and S. Mcquaid, Persistent endothelial abnormalities and blood-brain barrier leak in primary and secondary progressive multiple sclerosis, Neuropathol Appl Neurobiol, vol.33, pp.86-98, 2007.

D. A. Compston, B. P. Morgan, and A. K. Campbell, Immunocytochemical localization of the terminal complement complex in multiple sclerosis, Neuropathol Appl Neurobiol, vol.15, pp.307-323, 1989.

M. H. Barnett, J. D. Parratt, E. S. Cho, and J. W. Prineas, Immunoglobulins and complement in postmortem multiple sclerosis tissue, Ann Neurol, vol.65, pp.32-46, 2009.

M. K. Storch, S. Piddlesden, M. Haltia, M. Iivanainen, P. Morgan et al., Multiple sclerosis: in situ evidence for antibody-and complement-mediated demyelination, Ann Neurol, vol.43, pp.465-71, 1998.

H. E. Feucht, Complement C4d in graft capillaries -the missing link in the recognition of humoral alloreactivity, Am J Transplant, vol.3, pp.646-52, 2003.

M. H. Barnett and J. W. Prineas, Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion, Ann Neurol, vol.55, pp.458-68, 2004.

C. Larochelle, J. I. Alvarez, and A. Prat, How do immune cells overcome the bloodbrain barrier in multiple sclerosis?, FEBS Lett, vol.585, pp.3770-80, 2011.

A. Dressel, D. Mirowska-guzel, C. Gerlach, and F. Weber, Migration of T-cell subsets in multiple sclerosis and the effect of interferon-beta1a, Acta Neurol Scand, vol.116, pp.164-172, 2007.

M. Koch, W. Den-dunnen, O. G. Sie, D. Keyser, and J. , A fatal demyelinating illness in a young woman 10 weeks post partum, Lancet Neurol, vol.4, pp.129-163, 2005.

L. I. Levin, K. L. Munger, and M. V. Rubertone, Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis, JAMA, vol.293, pp.2496-500, 2005.

S. Ludwin and S. Jacobson, Epstein-Barr Virus and MS:Causality or Association?, Int MS J, vol.17, pp.39-43, 2011.

L. K. Selin, M. F. Wlodarczyk, and A. R. Kraft, Heterologous immunity: immunopathology, autoimmunity and protection during viral infections, Autoimmunity, vol.44, pp.328-375, 2011.

C. Vink, P. S. Beisser, and C. A. Bruggeman, Molecular mimicry by cytomegaloviruses. Function of cytomegalovirus-encoded homologues of G protein-coupled receptors, MHC class I heavy chains and chemokines, Intervirology, vol.42, pp.342-351, 1999.

S. Frankild, R. J. De-boer, O. Lund, M. Nielsen, and C. Kesmir, Amino acid similarity accounts for T cell cross-reactivity and for ''holes'' in the T cell repertoire, PLoS One, vol.3, p.1831, 2008.

C. Casiraghi, K. Dorovini-zis, and M. S. Horwitz, Epstein-Barr virus infection of human brain microvessel endothelial cells: a novel role in multiple sclerosis, J Neuroimmunol, vol.230, pp.173-180, 2011.

A. Ascherio, K. L. Munger, and E. T. Lennette, Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study, JAMA, vol.286, pp.3083-3091, 2001.

C. N. Martyn, M. Cruddas, and D. A. Compston, Symptomatic Epstein-Barr virus infection and multiple sclerosis, J Neurol Neurosurg Psychiatry, vol.56, pp.167-175, 1993.

K. L. Munger, L. I. Levin, E. J. O'reilly, K. I. Falk, and A. Ascherio, Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel, Mult Scler, vol.17, pp.1185-93, 2011.

M. Munch, K. Riisom, T. Christensen, A. Moller-larsen, and S. Haahr, The significance of Epstein-Barr virus seropositivity in multiple sclerosis patients?, Acta Neurol Scand, vol.97, pp.171-175, 1998.

H. J. Wagner, M. Hornef, H. M. Teichert, and H. Kirchner, Sex difference in the serostatus of adults to the Epstein-Barr virus, Immunobiology, vol.190, pp.424-433, 1994.

T. R. Nielsen, M. Pedersen, K. Rostgaard, M. Frisch, and H. Hjalgrim, Correlations between Epstein-Barr virus antibody levels and risk factors for multiple sclerosis in healthy individuals, Mult Scler, vol.13, pp.420-423, 2007.

R. Patarca and M. A. Fletcher, Structure and pathophysiology of the erythrocyte membrane-associated Paul-Bunnell heterophile antibody determinant in Epstein-Barr virus-associated disease, Crit Rev Oncog, vol.6, pp.305-331, 1995.

D. Lair, S. Coupel, and M. Giral, The effect of a first kidney transplant on a subsequent transplant outcome: an experimental and clinical study, Kidney Int, vol.67, pp.2368-75, 2005.

B. G. Weinshenker, P. C. O'brien, and T. M. Petterson, A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease, Ann Neurol, vol.46, pp.878-86, 1999.

K. Gwathmey, R. A. Balogun, and T. Burns, Neurologic indications for therapeutic plasma exchange: an update, J Clin Apher, vol.26, pp.261-269, 2011.

J. F. Kurtzke and N. Delasnerie-laupretre, Reflection on the geographic distribution of multiple sclerosis in France, Acta Neurol Scand, vol.93, pp.110-117, 1996.

J. F. Kurtzke, A reassessment of the distribution of multiple sclerosis. Part one, Acta Neurol Scand, vol.51, pp.110-146, 1975.

S. L. Silins, M. A. Sherritt, and J. M. Silleri, Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load, Blood, vol.98, pp.3739-3783, 2001.

J. O. Fleming and T. D. Cook, Multiple sclerosis and the hygiene hypothesis, Neurology, vol.67, pp.2085-2091, 2006.

J. O. Fleming, A. Isaak, and J. E. Lee, Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study, Mult Scler, vol.17, pp.743-54, 2011.

M. Hedlund, V. Padler-karavani, N. M. Varki, and A. Varki, Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression, Proc Natl Acad Sci, vol.105, pp.18936-18977, 2008.

K. Lauer, The risk of multiple sclerosis in the USA in relation to sociogeographic features: a factor-analytic study, J Clin Epidemiol, vol.47, pp.43-51, 1994.